We aimed to evaluate the relationship between the use of GLP-1 receptor agonists and the occurrence of 6 kinds of thyroid disorders.
Glucagon-like Peptide-1 receptor agonists (GLP-1RAs) are antidiabetic medications, with conflicting reports about their relationship with thyroid diseases. This study investigates their effects on thyroid function and nodules in patients with diabetes.
Clinicians frequently reach out to Catherine Varney, DO, asking if its safe to prescribe glucagon-like peptide 1 receptor agonists (GLP-1 RAs) to patients with thyroid disorders, such... This systematic review aims to critically evaluate the available evidence - and, more explicitly, to characterize the substantial evidence gap - concerning the effects of GLP-1 receptor agonists on thyroid function tests. The increasing utilization of Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) in managing type 2 diabetes mellitus has raised interest regarding their impact on thyroid... Clinicians frequently reach out to Catherine Varney, DO, asking if its safe to prescribe glucagon-like peptide 1 receptor agonists (GLP-1 RAs) to patients with thyroid disorders, such as hypothyroidism, goiter, hyperthyroidism, and nodules.
This systematic review aims to critically evaluate the available evidence - and, more explicitly, to characterize the substantial evidence gap - concerning the effects of GLP-1 receptor agonists on thyroid function tests.
This particular example perfectly highlights why Glp-1 Receptor Agonists For Adrenal Thyroid Function is so captivating.
The increasing utilization of Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) in managing type 2 diabetes mellitus has raised interest regarding their impact on thyroid...
